OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors
Helena Costa Verdera, Carmen Unzu, Erika Valeri, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 17-18, pp. 836-852
Closed Access | Times Cited: 14

Showing 14 citing articles:

Liver‐directed gene therapy for inherited metabolic diseases
Julien Baruteau, Nicola Brunetti‐Pierri, Paul Gissen
Journal of Inherited Metabolic Disease (2024) Vol. 47, Iss. 1, pp. 9-21
Open Access | Times Cited: 15

Filtering through AAV Capsid Libraries for Effective Kidney Gene Transfer
Aravind Asokan, Matthew H. Wilson
Kidney International (2025)
Closed Access

Challenges in Humoral Immune Response to Adeno-Associated Viruses Determination
Daria A. Naumova, Tatyana Krokunova, Denis Maksimov, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 816-816
Open Access

AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain
Helena Costa Verdera, Vasco Meneghini, Zachary Fitzpatrick, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy
Pasqualina Colella
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 6, pp. 703-719
Closed Access | Times Cited: 3

DNA Contamination Within Recombinant Adeno Associated Virus (AAV) Preparations Correlates with Decreased CD34+ Cell Clonogenic Potential
Christopher R. Luthers, Sung-Min Ha, Annika Mittelhauser, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101334-101334
Open Access | Times Cited: 3

Characterization of residual microRNAs in AAV vector batches produced in HEK293 mammalian cells and Sf9 insect cells
Magalie Penaud‐Budloo, Émilie Lecomte, Quentin Lecomte, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101305-101305
Closed Access | Times Cited: 2

AAV vectors trigger DNA damage responses and STING-dependent inflammation in human CNS cells
Helena Costa Verdera, Vasco Meneghini, Zachary Fitzpatrick, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1

Essential role of pre-existing humoral immunity in TLR9-mediated type I IFN response to recombinant AAV vectors in human whole blood
Nada S. Alakhras, Christopher A. Moreland, Li Chin Wong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Vision on gyrate atrophy: why treat the liver?
Iolanda Boffa, Nicola Brunetti‐Pierri
EMBO Molecular Medicine (2023) Vol. 16, Iss. 1, pp. 8-9
Open Access | Times Cited: 3

Gene Therapy in the Light of Lifestyle Diseases: Budesonide, Acetaminophen and Simvastatin Modulates rAAV Transduction Efficiency
Żaneta Słyk, Natalia Stachowiak, Maciej Małecki
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1213-1213
Open Access

In Vivo Selection of S/MAR Sequences to Favour AAV Episomal Maintenance in Dividing Cells
Andrea Llanos-Ardaiz, Aquilino Lantero, Leire Neri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12734-12734
Open Access

Page 1

Scroll to top